Biotech by today's price change
How far the share price has moved since the previous close.
Repligen leads the 24 biotech ranked by today's price change, at +2.97%, ahead of CG Oncology (+1.34%) and CRISPR Therapeutics (+0.81%). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Repligen+2.97%
- Median
- -0.37%
- Combined market value
- TRY 42.41T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | RepligenRGEN · Health Care | +2.97% | TRY 538.4B | TRY 8,422.87 | 2.97% up | 5% up | ||
| 2 | CG OncologyCGON · Health Care | +1.34% | TRY 360.4B | TRY 4,034.91 | 1.34% up | 85% up | ||
| 3 | CRISPR TherapeuticsCRSP · Health Care | +0.81% | TRY 198B | TRY 2,041.41 | 0.81% up | 21% down | ||
| 4 | ImmunovantIMVT · Health Care | +0.51% | TRY 348.4B | TRY 1,683.57 | 0.51% up | 43% up | ||
| 5 | Adaptive BiotechnologiesADPT · Health Care | +0.14% | TRY 232.9B | TRY 1,438.95 | 0.14% up | 88% up | ||
| 6 | Bio-TechneTECH · Health Care | +0.12% | TRY 576.2B | TRY 3,667.73 | 0.12% up | 26% up | ||
| 7 | argenxARGX · Health Care | -0.02% | TRY 3T | TRY 47,779.87 | 0.02% down | 4% up | ||
| 8 | QiagenQGEN · Health Care | -0.07% | TRY 517.8B | TRY 2,507.44 | 0.07% down | 12% up | ||
| 9 | VaxcytePCVX · Health Care | -0.20% | TRY 473.3B | TRY 2,989.87 | 0.20% down | 22% up | ||
| 10 | Kodiak SciencesKOD · Health Care | -0.30% | TRY 318.3B | TRY 4,867.61 | 0.30% down | 396% up | ||
| 11 | Krystal BiotechKRYS · Health Care | -0.32% | TRY 444.8B | TRY 15,009.86 | 0.32% down | 46% up | ||
| 12 | ExelixisEXEL · Health Care | -0.32% | TRY 840.3B | TRY 3,443.79 | 0.32% down | 63% up | ||
| 13 | Revolution MedicinesRVMD · Health Care | -0.41% | TRY 1.77T | TRY 8,171.45 | 0.41% down | 131% up | ||
| 14 | Halozyme TherapeuticsHALO · Health Care | -0.51% | TRY 549.1B | TRY 4,815.91 | 0.51% down | 37% up | ||
| 15 | Neurocrine BiosciencesNBIX · Health Care | -0.55% | TRY 842.3B | TRY 8,322.00 | 0.55% down | 20% up | ||
| 16 | BioNTechBNTX · Health Care | -0.64% | TRY 1.05T | TRY 4,252.79 | 0.64% down | 16% down | ||
| 17 | ImmunityBioIBRX · Health Care | -0.64% | TRY 333.7B | TRY 313.71 | 0.64% down | 193% up | ||
| 18 | Kymera TherapeuticsKYMR · Health Care | -0.83% | TRY 518.9B | TRY 6,078.08 | 0.83% down | 87% up | ||
| 19 | ModernaMRNA · Health Care | -0.88% | TRY 4.18T | TRY 10,338.95 | 0.88% down | 755% up | ||
| 20 | Twist BioscienceTWST · Health Care | -1.27% | TRY 380.2B | TRY 5,577.25 | 1.27% down | 340% up | ||
| 21 | Gilead SciencesGILD · Health Care | -1.43% | TRY 10.5T | TRY 8,464.73 | 1.43% down | 33% up | ||
| 22 | AmgenAMGN · Health Care | -1.45% | TRY 12.31T | TRY 22,762.43 | 1.45% down | 34% up | ||
| 23 | BiogenBIIB · Health Care | -1.51% | TRY 1.84T | TRY 12,457.78 | 1.51% down | 49% up | ||
| 24 | Scholar Rock HoldingSRRK · Health Care | -1.77% | TRY 272.5B | TRY 2,233.32 | 1.77% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4363 TRY).
Questions and answers
Which biotech rank first by today's price change?
Repligen (+2.97%), CG Oncology (+1.34%) and CRISPR Therapeutics (+0.81%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 14:31 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of TRY 42.41T as of 18 Nov 2026, 14:31 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.